Latest News & Features
Americas
Irish drugs producer Horizon Pharma has entered into a definitive agreement with Raptor Pharmaceuticals in which Horizon will buy the US biopharmaceutical company for $800 million. 14 September 2016
Americas
Biosimilars company Apobiologix has won a patent infringement litigation against Amgen centring on the drugs Grastofil and Lapelga. 13 September 2016
Asia
Pfizer has sued Indian generic company Sun Pharma for allegedly infringing patents centring on Xeljanz, a treatment for rheumatoid arthritis. 13 September 2016
Americas
A man has been arrested by special agents from US Immigration and Customs Enforcement’s Homeland Security Investigations unit for selling illicit goods, including counterfeit pharmaceuticals. 13 September 2016
Big Pharma
The EU General Court has backed the European Commission’s decision to fine pharma company Lundbeck and a number of generic producers. 12 September 2016
Americas
The US Court of Appeals for the Federal Circuit affirmed a ruling from a district court yesterday in a case between UCB and Yeda Research and Development, finding that UCB did not infringe the patent in dispute. 9 September 2016
Americas
The US Federal Trade Commission announced yesterday that it has approved a final order in Mylan’s $7.2 billion acquisition of Meda, a Swedish drug maker, deciding that the activity would be anticompetitive. 9 September 2016
Americas
Aralez Pharmaceuticals has acquired the US and Canadian rights to Zontivity in an agreement with Merck. 8 September 2016
Asia
Japan’s government officials have warned the UK that the Asian country may reconsider its research and development activities in the UK following Brexit. 8 September 2016
Americas
The US District Court for the Southern District of Florida ruled yesterday that Apotex did not infringe Amgen patents centring on its biologic drug Neulasta. 7 September 2016